Medtronic (XSWX:MDT) PE Ratio: 22.06 (As of Jun. 25, 2026) — 23% Below Median


XSWX:MDT Medtronic PLC XSWX:MDT
21 GF Score
Price CHF65.29
GF Value CHF80.97
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic PE Ratio?

Medtronic XSWX:MDT +1.21% 21 PE Ratio is 22.06 as of Jun. 25, 2026, which is 23% below its 10-year median of 28.59. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-25), Medtronic's share price is CHF65.29. Medtronic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was CHF2.96. Therefore, Medtronic's PE Ratio for today is 22.06.

Good Sign:

Medtronic PLC stock PE Ratio (=21.48) is close to 10-year low of 19.66.

During the past 13 years, Medtronic's highest PE Ratio was 61.31. The lowest was 19.66. And the median was 28.59.

Medtronic's EPS (Diluted) for the three months ended in Apr. 2026 was CHF0.76. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was CHF2.96.

As of today (2026-06-25), Medtronic's share price is CHF65.29. Medtronic's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was CHF4.39. Therefore, Medtronic's PE Ratio without NRI ratio for today is 14.88.

During the past 13 years, Medtronic's highest PE Ratio without NRI was 37.38. The lowest was 12.93. And the median was 17.70.

Medtronic's EPS without NRI for the three months ended in Apr. 2026 was CHF1.22. Its EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was CHF4.39.

During the past 12 months, Medtronic's average EPS without NRI Growth Rate was 0.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 1.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.20% per year.

During the past 13 years, Medtronic's highest 3-Year average EPS without NRI Growth Rate was 28.90% per year. The lowest was -2.40% per year. And the median was 11.40% per year.

Medtronic's EPS (Basic) for the three months ended in Apr. 2026 was CHF0.76. Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 was CHF2.97.

Back to Basics: PE Ratio


Medtronic  (XSWX:MDT) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Medtronic PE Ratio Related Terms


Medtronic PE Ratio Historical Data

* Premium members only.

The historical data trend for Medtronic's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic PE Ratio Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.98 32.25 29.07 23.48 21.71

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.48 24.86 24.45 28.68 21.71

XSWX:MDT vs SYK, BSX, EW: PE Ratio Comparison

For the Medical Devices subindustry, Medtronic's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's PE Ratio falls into.


XSWX:MDT
21GF Score
Medtronic PLC XSWX:MDT
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Medtronic's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=65.29/2.959
=22.06

Medtronic's Share Price of today is CHF65.29.
Medtronic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.96.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 22.06 mean?
Medtronic (XSWX:MDT) has a PE Ratio of 22.06 as of Jun. 25, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Medtronic and its competitors. This is 23% below median its historical median of 28.59. Over the past decade, Medtronic's PE Ratio has ranged from 19.66 to 61.31.
Is Medtronic's PE Ratio too high?
Medtronic's current PE Ratio of 22.06 is 23% below median its 10-year median of 28.59. Over the past 10 years, this metric has ranged from a low of 19.66 to a high of 61.31. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's PE Ratio compare to SYK and BSX?
Medtronic's PE Ratio of 22.06 can be compared against companies in the Medical Devices & Instruments industry. Historically, Medtronic's own PE Ratio has ranged from 19.66 to 61.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Medical Devices & Instruments company?
A good PE Ratio depends on the Medical Devices & Instruments industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Medtronic and its competitors. Medtronic's current PE Ratio is 22.06, which is 23% below median its own 10-year median of 28.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current PE Ratio is 22.06, which is 23% below median its 10-year median of 28.59. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current PE Ratio is 22.06 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for XSWX:MDT:

  • PE Ratio: 22.06 (23% below median its 10-year median of 28.59)
  • GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
  • GF Score™: 21/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score

Get the complete analysis for XSWX:MDT

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF65.29
Price
CHF80.97
GF Value